Antigen presenting and primary in vitro sensitizing capacity of CD1a+ dendritic cells generated from human blood.
Paul Gerson Unna Skin Research Center, Beiersdorf AG, Hamburg, Germany.
J
J
Degwert
F
F
Steckel
U
U
Hoppe
D017951:Antigen Presentation; D018949:Antigens, CD1 / Q000378:metabolism*; D001773:Blood Cells / Q000187:drug effects / Q000276:immunology*; D003713:Dendritic Cells / Q000187:drug effects / Q000276:immunology*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology; D006684:HLA-DR Antigens / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000276:immunology; D008213:Lymphocyte Activation; D013601:T-Lymphocytes / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
D018949:Antigens, CD1; D006684:HLA-DR Antigens; D014409:Tumor Necrosis Factor-alpha; D016178:Granulocyte-Macrophage Colony-Stimulating Factor